Status:
COMPLETED
Complementary Therapies for the Reduction of Side Effects During Chemotherapy for Breast Cancer
Lead Sponsor:
Heidelberg University
Collaborating Sponsors:
Hector-Stiftung
Cefak KG, Kempten
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-75 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine wether a complementary therapy consisting of a combined medication of selenium, milk thistle, goldenrod and bromelain and a consultation concerning nutrition ...
Detailed Description
patients were randomized to receive: (a) individual nutrition consultation with recommendations for physical activity before or on the first day of chemotherapy together with daily oral medication con...
Eligibility Criteria
Inclusion
- Indication for chemotherapy for breast cancer for at least 3 cycles
Exclusion
- Prior chemotherapy within 12 months
- use of herbal or nutritional supplements or other complementary or alternative medications ≥ 7 days prior to start of chemotherapy and during the trial
- allergy to study medication
- Selenium intoxication
- Current use of cumarins or other medication influencing the coagulation system
- Edema in case of impaired cardial or renal function
- Other severe medical condition
- Psychiatric or central neurological disorders
- Regular fluid intake \< 2000 ml per day
Key Trial Info
Start Date :
August 1 2003
Trial Type :
INTERVENTIONAL
End Date :
December 1 2005
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00160901
Start Date
August 1 2003
End Date
December 1 2005
Last Update
April 19 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Complementary and Integrative Medicine
Heidelberg, Baden-Wurttemberg, Germany, D-69115